What Comes First In Consumer Sector: FDA Excessive Claims Finding Or Facility Inspection?
This article was originally published in The Pink Sheet Daily
Executive Summary
Recent warning letters to Reviva Labs and Ageless Derma manufacturer Crescent Health Center cite claims violations brought to FDA's attention through inspections of the companies' facilities. It's possible, however, that conspicuous website claims that overstep cosmetic boundaries are prompting inspections.